- Home
- PSTG vs MRNA Comparison
PSTG vs MRNA Comparison
Compare PSTG & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTG
- MRNA
- Stock Information
- Founded
- PSTG 2009
- MRNA 2010
- Country
- PSTG United States
- MRNA United States
- Employees
- PSTG N/A
- MRNA N/A
- Industry
- PSTG Electronic Components
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PSTG Technology
- MRNA Health Care
- Exchange
- PSTG Nasdaq
- MRNA Nasdaq
- Market Cap
- PSTG 17.4B
- MRNA 16.5B
- IPO Year
- PSTG 2015
- MRNA 2018
- Fundamental
- Price
- PSTG $64.86
- MRNA $39.39
- Analyst Decision
- PSTG Buy
- MRNA Hold
- Analyst Count
- PSTG 21
- MRNA 19
- Target Price
- PSTG $71.95
- MRNA $79.50
- AVG Volume (30 Days)
- PSTG 4.0M
- MRNA 9.0M
- Earning Date
- PSTG 12-03-2024
- MRNA 02-20-2025
- Dividend Yield
- PSTG N/A
- MRNA N/A
- EPS Growth
- PSTG 69.90
- MRNA N/A
- EPS
- PSTG 0.36
- MRNA N/A
- Revenue
- PSTG $3,078,127,000.00
- MRNA $5,081,000,000.00
- Revenue This Year
- PSTG $12.73
- MRNA N/A
- Revenue Next Year
- PSTG $12.32
- MRNA N/A
- P/E Ratio
- PSTG $176.61
- MRNA N/A
- Revenue Growth
- PSTG 7.97
- MRNA N/A
- 52 Week Low
- PSTG $34.32
- MRNA $35.80
- 52 Week High
- PSTG $70.41
- MRNA $170.47
- Technical
- Relative Strength Index (RSI)
- PSTG 57.92
- MRNA 39.16
- Support Level
- PSTG $61.01
- MRNA $37.44
- Resistance Level
- PSTG $66.99
- MRNA $44.38
- Average True Range (ATR)
- PSTG 2.87
- MRNA 2.57
- MACD
- PSTG 0.01
- MRNA 0.06
- Stochastic Oscillator
- PSTG 64.59
- MRNA 19.55
About PSTG Pure Storage Inc.
Pure Storage Inc is a U.S.-based company that provides an enterprise data storage platform that transforms business through a dramatic increase in performance and reduction in complexity and costs. It generates revenue from two sources: product revenue which includes the sale of integrated storage hardware and embedded operating system software and; subscription services revenue which includes Evergreen Storage subscriptions, a unified subscription which includes Pure as-a-Service, and Cloud Block Store, and Portworx. Subscription services revenue also includes professional services offerings such as installation and implementation consulting services.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.